暂时性前列腺支架置入与雄激素抑制：一种治疗恶性前列腺潴留的新型微创方法。
Temporary prostatic stenting and androgen suppression: a new minimally invasive approach to malignant prostatic retention.
作者信息
Anson K M, Barnes D G, Briggs T P, Watson G M, Miller R A
机构信息
Department of Urology and Minimally Invasive Surgery, Whittington Hospital, Highgate Hill, London, UK.
出版信息
J R Soc Med. 1993 Nov;86(11):634-6. doi: 10.1177/014107689308601107.
Urinary retention secondary to carcinoma of the prostate is usually treated by 'channel' transurethral resection of the prostate either performed alone or in combination with hormone manipulation. The combination of temporary prostatic stenting and androgen suppression may reduce the morbidity and mortality associated with this treatment. We report on our initial experience using the combination of a temporary prostatic stent with the oral anti-androgen Flutamide in 10 patients with urinary retention or severe bladder outflow obstruction secondary to prostatic carcinoma. Eight of the ten patients successfully voided and maintained normal voiding after stent removal. There were two treatment failures requiring prostatic resection. We believe the cost of stenting and medication is entirely justified by patient preference and clearance of hospital beds.
前列腺癌继发的尿潴留通常通过经尿道前列腺“通道”切除术单独治疗或与激素治疗联合进行。临时前列腺支架置入与雄激素抑制相结合可能会降低这种治疗相关的发病率和死亡率。我们报告了我们最初使用临时前列腺支架与口服抗雄激素药物氟他胺联合治疗10例因前列腺癌导致尿潴留或严重膀胱流出道梗阻患者的经验。10例患者中有8例在支架取出后成功排尿并维持正常排尿。有2例治疗失败需要进行前列腺切除术。我们认为，支架置入和药物治疗的费用完全因患者的偏好和病床的腾空而合理。
Zotero 插件